生物医药
Biotechnology 概念板块聚焦生命科学与生物工程，核心赛道涵盖基因编辑、细胞与基因治疗、抗体药物、疫苗、合成生物与体外诊断。板块总市值达 918.48 billion HKD，24h 涨跌幅 -0.20%，14 个标的中上涨 6 个（占比 42.86%），下跌 8 个（占比 57.14%）。领涨个股为 金斯瑞生物科技 (01548)，24h 涨幅 +4.47%。在温和盘整中，以龙头股为主导的韧性表明这只是暂停，而非趋势反转。围绕即将到来的催化事件进行动量交易；在回调时逢低吸纳现金充足的创新型公司，优先考虑经证实的管线和风险控制，而非投机性标的。
名称 | 最新价 | 涨跌幅 | 最新价 / 涨跌幅 | 走势图 | 价格区间 | 操作 |
|---|---|---|---|---|---|---|
 药明生物02269 | HK$38.66¥33.41 | -1.12%-¥0.38 | HK$38.66 -1.12% | ¥33.25¥34.27 | ||
 药明康德02359 | HK$157.0¥135.6 | -0.25%-¥0.3 | HK$157.0 -0.25% | ¥135.1¥138.1 | ||
 百济神州06160 | HK$199.7¥172.5 | +0.25%+¥0.4 | HK$199.7 +0.25% | ¥170.9¥173.1 | ||
 金斯瑞生物科技01548 | HK$16.82¥14.53 | +4.47%+¥0.62 | HK$16.82 +4.47% | ¥13.88¥14.53 | ||
 康方生物09926 | HK$98.60¥85.21 | -0.90%-¥0.77 | HK$98.60 -0.90% | ¥84.13¥86.16 | ||
 科伦博泰生物－B06990 | HK$513.5¥443.7 | -0.09%-¥0.4 | HK$513.5 -0.09% | ¥438.1¥449.4 | ||
 荣昌生物09995 | HK$85.65¥74.02 | +2.94%+¥2.11 | HK$85.65 +2.94% | ¥71.90¥74.54 | ||
 康诺亚－B02162 | HK$82.30¥71.12 | -0.60%-¥0.43 | HK$82.30 -0.60% | ¥70.30¥71.99 | ||
 药明合联02268 | HK$54.35¥46.97 | -2.16%-¥1.03 | HK$54.35 -2.16% | ¥46.58¥48.65 | ||
 再鼎医药09688 | HK$14.87¥12.85 | -3.31%-¥0.44 | HK$14.87 -3.31% | ¥12.71¥13.33 | ||
 泰格医药03347 | HK$37.84¥32.70 | +1.72%+¥0.55 | HK$37.84 +1.72% | ¥31.94¥33.10 | ||
 诺诚健华09969 | HK$13.91¥12.02 | +0.79%+¥0.09 | HK$13.91 +0.79% | ¥11.87¥12.15 | ||
 复宏汉霖02696 | HK$56.00¥48.39 | -0.17%-¥0.08 | HK$56.00 -0.17% | ¥47.87¥48.87 | ||
 君实生物－B01877 | HK$18.90¥16.33 | +2.77%+¥0.44 | HK$18.90 +2.77% | ¥15.89¥16.36 |